4.22.2022
6.16.2021
8.24.2021 
4.5.2021 
Lucid Motor’s Lucid Air has won MotorTrend’s Car of the Year award, marking the first time any automaker’s inaugural product has received this title.
Venrock has passion for solving big problems, respect for entrepreneurs, and deep empathy for the process of company building. They are not just our investors, they are our partners every step of the way.
Nathan Gunn, Erin Palm, Karthik Rajan, and Punit Soni
Suki
There was never any question about who we wanted as our Devoted co-founders. And they have outperformed on every dimension.
Ed and Todd Park
Devoted Health
Venrock's guidance in the early days of CloudFlare was a great resource. They have been a partner ever since.
Matthew Prince, Michelle Zatlyn and
Lee Holloway
CloudFlare
Our partners are an extension of our company, so we choose them carefully.
Tony Fadell and Matt Rogers
Nest
ABL Space Systems closed a $200M round, bringing their valuation to $2.4B. They aim to launch their RS1 rocket by the end of this year.
Candid conversations about entrepreneurship
Available on iTunes, SoundCloud and Stitcher
Listen here
Build the Future
Venrock partners with entrepreneurs to achieve what others believe is impossible.
We Invest in Technology
- Intelligent Enterprise & AI
- Security & Infrastructure
- Fintech
- Healthcare IT
- Defense & Aerospace
- Robotics & Autonomy
- Consumer
Intelligent Enterprise & AI
AI is making software radically smarter, unlocking the value of unstructured data and enabling predictive capabilities to solve business problems in fundamentally new ways while requiring far less effort from users. The opportunity for value creation is more profound than even the shift from on-premise to Cloud.
Security & Infrastructure
Rapidly evolving enterprise infrastructure is accelerating hybrid cloud architecture and software development processes. A lack of sufficiently skilled workers for modernizing infrastructure and thwarting adversaries is threatening these changes and impacting how software is built, infrastructure is managed, and threats are mitigated.
Fintech
Financial services have traditionally been delivered through massive brick and mortar networks with armies of workers and paper-intensive processes. Fintechs are removing middleman fees and opacity and enabling innovative new services. This increased efficiency and transparency yields radically new offerings at better prices.
Healthcare IT
The largest industry in the United States is being completely reconstructed as the twin tsunamis of incentives and information are brought to bear on an archaic system. Capitalism and information technology will create a dramatically more efficient healthcare system that provides better care.
Defense & Aerospace
Technology is changing the nature of national security, making the defense sector a more active early adopter of emerging technologies in AI, big data, cybersecurity, quantum computing and aerospace. The defense sector is also fueling a thriving space economy, which is revolutionizing critical services globally across communication, sensing, intelligence and connectivity.
Robotics & Autonomy
Demand for robots and autonomy across retail, material handling, defense and other markets is a $120B+ market growing 20% annually. We look for the best and brightest roboticists who obsess over solving hard customer problems.
Consumer
The size of the global, internet-connected audience allows technology products to influence consumer behavior and lives on an unprecedented scale. We partner with founders obsessed with product and user experience who aim to fundamentally improve how we do things as consumers.
We Invest in Healthcare
- Therapeutics-Small Molecules
- Therapeutics-Biologics
- Medical Devices
- Diagnostics & New Technologies
Therapeutics-Small Molecules
Leveraging novel biology and advances in chemistry, we seek out the most revolutionary small molecule therapeutics and platforms that have the opportunity to create large shareholder value and save millions of lives.
Therapeutics-Biologics
Drawing on decades of experience funding many of the leaders in biotechnology, we continue to invest in proteins and antibodies, as well as new therapeutic modalities, that target diseases unattainable or poorly treated by small molecules.
Medical Devices
Today, there are very interesting opportunities for novel, innovative device interventions to address complex diseases, as well as consumer appetites.
Diagnostics & New Technologies
The industrialization of DNA sequencing over the last decade has created robust and cost efficient methods to diagnostics. The next decade will be even more fruitful, with novel technologies and content creating ever more powerful products to assist in the treatment of patients.
Insights
News
Investment Team
Contact
Silicon Valley
3340 Hillview Avenue,
Palo Alto, California 94304
Phone 650 561 9580
Fax 650 561 9180
New York
7 Bryant Park, 23rd Floor
New York, NY 10018
Phone 212.444.4100
Fax 212.444.4101
Boston
34 Farnsworth St, 3rd Floor,
Boston, MA 02210
Phone 617.995.2000
Fax 617.995.2001